1Alvarez Olmos MI,Oberhelman RA.Probiotic agents and infectious disease:a modern perspective on atraditional therapy[J].Clin Infect Dis,2001,32:1567-1576.
2Saavedra JM.Clinical applications of probiotic agents[J].AmJ Clin Nutr,2001,73:1147-1151.
3Salminen S,Arvilommj H.Probiotics demonstrating efficacy in clinical settings[J].Clin Infect Dis,2001,32:1577-1578.
5Fuller R,Gibson GR.Probiotics and prebiotics:microflora management for improved gut health[J].Clin Microbiol Infect,1998,4:477-480.
6Jorg Schlaak,Elisabeth Hermann,Mark Ringhoffer,et al.Predominance of Thl type T cells in synovial fluid of patients with Yersinia induced reactive arthritis[J].EuJ Immunol,1992,22:2771-2776.
7Kalliomaki M,Salminen S,Kero P,et al.Probiotics in primary prevention of atopic disease:a randomized placebo-controlled trial[J].Lancet,2001,357:1076-1079.
8Fang Yan and D,Brent,Polk.Probiotic bacterium prevents cytokine induced apoptosisinin testinal epithelial cells[J].Biolog Chem,2002,277(52):50 959-50 965.
